HOME >> MEDICINE >> NEWS
Drug cocktail prevents hepatitis B virus from recurring after liver transplant

Aiming to prevent recurrence of the hepatitis B virus (HBV) in post liver-transplant patients, UCLA researchers retrospectively reviewed survival rates of hepatitis B liver-transplantation patients. Their findings show that a combination of two drug therapies improved patient survival rates when compared to existing drug therapies given alone and that long-term treatment dramatically decreases recurrence of the disease.

The results, published in the May issue of the Annals of Surgery, showed the viral prophylaxis therapy or preventive treatment of hepatitis B immune globulin (HBIg) and lamivudine in combination prevents recurrence of HBV infection and lengthens patient survival rates following liver transplantation.

Researchers studied a total of 3,094 liver transplants performed at UCLA Medical Center from 1984 through April 2001. Of those, 191 transplant operations were performed on 166 patients afflicted with HBV cirrhosis. The patients were divided into four treatment groups: no prophylaxis, lamivudine monotherapy, HBIg monotherapy, or a lamivudine and HBIg combination.

When comparing the combination therapy to the monotherapy or no therapy, the HBV-free survival rates were considerably higher for patients who received the combination of HBIg and lamivudine. The one-year and three-year survival rates for the combination therapy were 92 percent and 81 percent, respectively. Survival rates for lamivudine alone were 72 percent and 62 percent. Survival rates for patients who were given HBIg alone were even lower at 45 percent and 36 percent.

Researchers also considered what effect therapy duration might have in HBV recurrence. With short-term HBIg monotherapy, HBV infection recurred in 60 percent of patients after transplant. With long term HBIg monotherapy, which is defined as greater than six months, 40 percent of the patients suffered HBV recurrence. But patients receiving long-term HBIg and lamivudine therapy had a dramatic redu
'"/>

Contact: Kirsten Holguin
kholguin@support.ucla.edu
310-794-0777
University of California - Los Angeles
29-Apr-2002


Page: 1 2 3

Related medicine news :

1. Screening for osteoporosis prevents hip fractures in older adults
2. Understanding how prostaglandin prevents gut injury during radiation therapy
3. Exercise prevents Parkinsons symptoms in lab model mimicking human form of the disease
4. Study finds once-daily Valcyte prevents serious viral infection after kidney transplant
5. Enzyme prevents lung damage in premature infants
6. Enoxaparin prevents stillbirth in pregnant women with clotting disorder
7. New drug prevents arrhythmias that cause sudden cardiac death
8. Detecting vitamin B12 deficiency prevents anaemia and memory loss
9. Drug prevents diabetes recurrence after islet cell transplantation
10. Gene targeting prevents memory loss in Alzheimers disease model
11. Combined drug therapy prevents progression of prostate enlargement

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
Breaking Medicine Technology:
Cached News: